254 related articles for article (PubMed ID: 35400175)
1. Species Distribution and Antifungal Susceptibilities of
Badali H; Cañete-Gibas C; McCarthy D; Patterson H; Sanders C; David MP; Mele J; Fan H; Wiederhold NP
J Clin Microbiol; 2022 May; 60(5):e0028022. PubMed ID: 35400175
[No Abstract] [Full Text] [Related]
2. Five-year surveillance study of clinical and environmental Triazole-Resistant Aspergillus fumigatus isolates in Iran.
Khojasteh S; Abastabar M; Haghani I; Valadan R; Ghazanfari S; Abbasi K; Ahangarkani F; Zarrinfar H; Khodavaisy S; Badali H
Mycoses; 2023 Feb; 66(2):98-105. PubMed ID: 36196507
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.
Badiee P; Boekhout T; Zarei Mahmoudabadi A; Mohammadi R; Ayatollahi Mousavi SA; Najafzadeh MJ; Soltani J; Hashemi J; Diba K; Ghadimi-Moghadam A; Salimi-Khorashad AR; Shokohi T; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Jun; 10(3):e0253921. PubMed ID: 35579442
[TBL] [Abstract][Full Text] [Related]
5. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.
Wang HC; Hsieh MI; Choi PC; Wu WL; Wu CJ;
Mycoses; 2023 Aug; 66(8):711-722. PubMed ID: 37186489
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Arendrup MC; Jensen RH; Cuenca-Estrella M
Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
[TBL] [Abstract][Full Text] [Related]
7. Determination of Azole Resistance and TR
Güngör Ö; Sampaio-Maia B; Amorim A; Araujo R; Erturan Z
Mycopathologia; 2018 Dec; 183(6):913-920. PubMed ID: 30187246
[TBL] [Abstract][Full Text] [Related]
8. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
[TBL] [Abstract][Full Text] [Related]
10. Trends in the activity of mold-active azole agents against
Pfaller MA; Carvalhaes CG; Rhomberg PR; Desphande LM; Castanheira M
J Clin Microbiol; 2024 Feb; 62(2):e0114123. PubMed ID: 38193696
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
[TBL] [Abstract][Full Text] [Related]
13. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type.
Duong TN; Le TV; Tran KH; Nguyen PT; Nguyen BT; Nguyen TA; Nguyen HP; Nguyen BT; Fisher MC; Rhodes J; Marks G; Fox GJ; Chen SC; Walsh MG; Barrs VR; Talbot J; Halliday CL; Sorrell TC; Day JN; Beardsley J
Environ Microbiol; 2021 Dec; 23(12):7632-7642. PubMed ID: 34232541
[TBL] [Abstract][Full Text] [Related]
14. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
15. Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
Wiederhold NP; Locke JB; Daruwala P; Bartizal K
J Antimicrob Chemother; 2018 Nov; 73(11):3063-3067. PubMed ID: 30032217
[TBL] [Abstract][Full Text] [Related]
16. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
[TBL] [Abstract][Full Text] [Related]
17. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
19. Pan-azole- and multi-fungicide-resistant
Celia-Sanchez BN; Mangum B; Gómez Londoño LF; Wang C; Shuman B; Brewer MT; Momany M
Appl Environ Microbiol; 2024 Apr; 90(4):e0178223. PubMed ID: 38557086
[No Abstract] [Full Text] [Related]
20. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
